Lawrence Otto Klein, Chief Executive Officer at Oruka Therapeutics, Inc. (ORKA), sold 2,452 shares at $95.71 ($235K) on 2026-09-15, disclosed to the SEC on 2026-09-15.
Open-market sale of $235k ORKA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ORKA | SELL | 2026-06-15 | $120K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $71K | — | Filing → |
| CRSP | SELL | 2021-03-25 | $24.1M | — | Filing → |